
The U.S. Preventive Services Task Force (USPSTF) has proposed lowering the recommended age for colon cancer screenings from 50 to 45. While this change is still under review and subject to public feedback, it is expected that insurers will be required to cover screenings for individuals aged 45 and older if the proposal is finalized.
The New York Times highlights that this recommendation is a departure from the task force’s usual stance, as they have often advocated for reduced screening in areas like cervical cancer and mammograms. This shift reflects the task force’s role in evaluating the risks and benefits of preventive care, which vary based on factors such as age, procedure specifics, and individual risk profiles.
As outlined in our guide to colon cancer prevention, the disease is increasingly affecting younger individuals, making 45 the new benchmark for screenings. The American Cancer Society has supported screening at 45 since their 2018 guidelines, with particular emphasis on its importance for Black Americans. While the USPSTF does not adjust screening ages by race, they stress that Black individuals should prioritize screenings due to higher risk factors.
According to CISNET modeling, there is no evidence to support race-specific screening strategies. However, the USPSTF acknowledges the higher rates of colorectal cancer incidence and mortality among Black adults and strongly advises healthcare providers to ensure that Black patients receive appropriate screening, follow-up, and treatment. The USPSTF also advocates for the development of healthcare systems that guarantee high-quality care throughout the screening and treatment process, with a particular focus on improving outcomes in Black communities facing health disparities.
What types of screenings are recommended?
Screening for colon cancer can involve a colonoscopy, recommended every decade, or less invasive stool-based tests, which require annual testing.
The USPSTF’s draft recommendation provides a chart detailing various screening methods and their recommended frequencies. Screenings are rated “A” for individuals aged 50 to 75 and “B” for those aged 45 to 49. Insurance typically covers procedures with an A or B rating. For individuals aged 75 to 85, the decision to screen should be made in consultation with a doctor, while no recommendation is provided for those over 85.
